U

University of Michigan | Kellogg Eye Center

Research site

(Unclaimed)

Location

24 Frank Lloyd Wright Drive, Lobby G/Suite 1500, Ann Arbor, Michigan, United States of America

Site insights

Top conditions

Top treatments

NT-501

Zimura

Lidocaine

Linsitinib

Parent organization

This site is a part of University of Michigan

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 20 total trials

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (LIDS)

The overall objective is to study the safety, pharmacokinetics and efficacy of linsitinib (a small molecule IGF-1R inhibitor) administered orally twi...

Active, not recruiting

Thyroid Diseases

Graves Ophthalmopathy

Drug: Placebo

Drug: Linsitinib

A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

The study consists of a randomized double-masked, placebo-controlled, parallel-group, multicenter trial with an optional open-label treatment period...

Enrolling

Thyroid Eye Disease

Other: Placebo

Biological: Teprotumumab

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

The purpose of this study is to evaluate the safety and efficacy of avacincaptad pegol intravitreal injection compared to Sham in participants with a...

Active, not recruiting

Stargardt's Macular Dystrophy

Drug: Sham

Drug: avacincaptad pegol